Systematic analysis of disease-linked rare germline variants reveals new classes of cancer predisposing genes
Song, S.; Koh, Y.; Kim, S.; Lee, S. M.; Kim, H. U.; Ko, J. M.; Lee, S.-H.; Yoon, S.-S.; Park, S.
Show abstract
Despite recent insights into cancer predisposition genes (CPGs), the contribution of rare germline variants to carcinogenesis remains unclear. Here, we examine the enrichment of rare germline variants in Mendelian disease-associated genes using PCAWG and the 1,000 Genomes Project. Using an integrative approach that considers disease classes, cellular pathways, and tissue expression profiles, we find that subsets of Online Mendelian Inheritance in Man (OMIM) genes are strong candidate CPGs. These genes were classified into five clusters suggesting diverse mechanisms underlie tumor progression. We further analyzed PAH gene which shows the strongest prevalence of rare germline variants in cancers (2.2%) compared to controls (0.7%). This enrichment was validated in two independent cancer cohorts and present the possibility of tumorigenesis by contributing immune-associated pathways. Our data argue that rare germline variants of Mendelian disease-associated genes contribute to cancer progression and suggest new CPG classifications that may underlie diverse tumorigenesis mechanisms.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cross-dataset pan-cancer detection: Correlating cell-free DNA fragment coverage with open chromatin sites across cell types 97%
- The genomic and epigenomic evolutionary history of papillary renal cell carcinomas 97%
- Identification of Relevant Genetic Alterations in Cancer using Topological Data Analysis 97%
Similar papers in this journal
Similar papers in this journal
- Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases 97%
- Genomic evolution of pancreatic cancer at single-cell resolution 96%
- Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants 96%
Similar papers in this journal
- The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity 96%
- Integrated Molecular Characterisation of the MAPK Pathways in Human Cancers 95%
- Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.